The value of treatment with non-steroidal antiinflammatory drugs (NSAIDs) is suggested by their widespread use, over 22 million prescriptions being issued each year.' Patients commonly suffer from adverse gastrointestinal effects, however. Avoidance of these would be eased if we had a fuller understanding of basic mechanisms and predisposing factors. Assessment is further hindered because peptic ulcer is common in the elderly even without NSAID treatment, there are no characteristic symptom patterns, patients with connective tissue diseases may be inherently more prone to gastrointestinal damage,2 there is a wide range of disorders for which NSAIDs are indicated, be it long term (rheumatoid arthritis, osteoarthritis) or acutely (soft tissue injuries), and there are at least 18 available generic NSAIDs.
Ulcer frequency
Duodenal ulcer has been accepted as a disease of the young or middle aged, but recent data suggest that the incidence of both gastric and duodenal ulcer, at least as judged by perforation rates, has increased markedly in the United Kingdom in the elderly over the past 25 years, whereas it has fallen substantially in younger people.' The reasons for this change are not clear, and we are left with the impression that there are specific factors which have made elderly people more prone to peptic ulceration and its 
Coincident disease in arthritis
It is difficult to determine whether patients suffering from one disease are at risk of another. Postmarketing surveillance has shown that the greater intensity of clinical surveillance, which is an inevitable consequence of disease, will increase the chances of a second disease being recognised. 12 Secondly, if an association between arthritis and ulcer is sought by examining the prevalence of ulcer in arthritis, and of arthritis in ulcer patients, the chances of detecting associations will be increased, but a spuriously high level of association by comparison with a reference value will also be noted. '3 There have nevertheless been repeated suggestions that the patient with arthritis, particularly rheumatoid disease, is inherently susceptible to peptic ulceration,24 though whether any increase represents a special property of the rheumatoid process, or is a general feature to be expected in those who are, say, marginally malnourished, is not clear. Platelet activating factor has been proposed as a mediator in the production of stress ulceration of the gastrointestinal tract and may explain the prevalence of gastrointestinal disturbance in chronic painful diseases such as rheumatoid arthritis. ' 25 This proportion was found to be larger than in inpatient or community controls matched by age and sex, with an approximately threefold increase in risk for both gastric and duodenal ulcer in individuals aged 60 and over. 26 Confounding seems unlikely to explain the differences, but the studies do not allow us to conclude whether NSAID ingestion predisposes to ulceration per se, or to complications in those with established ulcer. Caruso and Bianchi Porro, however, in a prospective endoscopic study noted that gastric erosions increased markedly in NSAID takers when endoscopic findings before and after treatment were compared. 6 There was an increased proportion of NSAID takers in patients with bleeding ulcer compared with controls, in contrast with the relative lack of ulcer complications in short term controlled trials of NSAID treatment. Furthermore, when groups of 6000 to 12 000 patients taking particular NSAIDs were followed up in post-marketing surveillance studies no differences in ulcer complication rates were noted in those given any of five different NSAIDs nor between rates in the absence or presence of treatment with these individual agents. 27 The apparently incompatible results of case control studies suggesting that NSAIDs may cause ulcer complications, and surveillance studies suggesting that they do not, can be reconciled if the likely incidence of ulcer complications is taken into account. Some 26 The total number of NSAID prescriptions issued has increased by over 10 million in the UK in recent years, with the elderly being most likely to receive treatment, but this rise probably accounts for a fifth to a q5uarter of the increase in total perforations noted. Nevertheless the coincidence between an increasing incidence of ulcer perforation in the elderly, and a rising rate of NSAID consumption in the same age group, suggests that it might be wise to keep the NSAID dosage as low as possible.
Investigation
There are no simple guidelines to separate those needing investigation of gastrointestinal symptoms from those who do not. The choice is usually made on symptomatic grounds even though there seems to be a high incidence of asymptomatic ulcer in patients with arthritis. Likewise there are no clear grounds for choosing between endoscopy and double contrast radiology examination, though experience in this age group favours endoscopy, particularly as a means of detecting small mucosal lesions and erosions and in examining the duodenal cap efficiently. Elderly and arthritic patients find endoscopy easier and generally prefer it to a barium meal, which requires considerable mobility on a hard x ray table to obtain optimal films. Modern fibre optic endoscopes are safe even in patients with advanced rheumatoid disease.
Management
When a patient taking a NSAID develops dyspepsia most clinicians will withdraw treatment altogether, or alternatively substitute another NSAID, or prescribe peptic ulcer therapy. The decision between these strategies has no rational basis. If 
